Clinical trial NCT04937179: The Effect of Ischemic Conditioning on Strength and Ambulation in Subjects with PAD
Official title: The Effect of Ischemic Conditioning on Strength and Ambulation in Subjects with Peripheral Artery Disease (PAD)
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Peripheral Arterial Disease
Peripheral Vascular Disease
Amputation
Lower Limb Amputation Knee
Lower Limb Amputation Above Knee (Injury)
Lower Limb Amputation Below Knee (Injury)
Lead sponsor: University of Illinois at Chicago
Sponsor class: OTHER
Collaborators: name: American Heart Association
First posted: 2021-06-23
Enrollment: 21
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: CROSSOVER
Primary purpose: BASIC_SCIENCE

Brief summary: Lower limb amputation is common in the United States, with approximately 150,000 amputations annually. Most individuals walking with a prosthesis demonstrate asymmetrical loading-i.e., they favor the amputated side by placing more weight and increased ground reaction forces through the intact limb-which likely contributes to increased metabolic cost of walking. Lack of adequate muscular strength in the lower limb to attenuate these forces places increased stress on the joints, which may be displaced proximally, and may play a role in reported knee and hip pain in the intact limb.

Lower limb muscle weakness following amputation has been well documented. Increasing quadriceps strength is important after an amputation because it is positively correlated with gait speed. Gait speed may also be associated with successful community mobility, which leads to improved quality of life following amputation. Individuals with amputation who resume an active lifestyle are able to maintain strength. However, these individuals represent a minority of persons with lower limb amputation; most individuals report more barriers than motivators to adopt an active lifestyle.

Ischemic conditioning (IC) may strengthen leg muscles and reduce the metabolic cost of activity after amputation. In IC, the limb is exposed to brief, repeated bouts of ischemia (reduced blood flow) immediately followed by reperfusion. IC has been shown to improve muscle performance in healthy and diseased populations. IC has also been used more recently in patients with peripheral artery disease (PAD) as an intervention to improve function, such as walking ability. Acute exposure to IC increases muscle strength and activation, both in healthy, active individuals and in those with severe neuromuscular dysfunction, such as stroke survivors. IC also attenuates muscular fatigue. Increased fatigue resistance at submaximal contraction levels following IC may be due to increased neural activation of skeletal muscle. Changes in neural activation of muscle may be particularly beneficial during cortical reorganization after amputation. Reduced quadriceps fatigue during submaximal activities may also drive changes in gait kinematics, such as increased knee flexion during loading and mid-stance. Exposure to IC may also increase the oxidative properties of skeletal muscle, offering a direct pathway to reduce metabolic cost. Therefore, IC may lead to cellular changes that lower the metabolic cost of activity.

The primary aim of this study is to quantify the benefits of acute and chronic IC on quadriceps strength and walking economy in individuals with PAD and history of lower limb amputation.


Eligibility criteria: Inclusion Criteria:

* 18 years or older
* Able to ambulate independently without the use of aids (i.e., walking cane)
* Able to walk at least 10 minutes continuously without stopping
* History of diagnosed peripheral artery disease.
* For Amputees: History lower limb unilateral transtibial or transfemoral amputation.

Exclusion Criteria:

* Inability to give informed consent
* neurological disorder that affects gait
* two or more falls within the previous 12 months
* currently pregnant (or intend to become pregnant while participating in study)
* history of any condition where fatiguing contractions or resisted leg contractions are contraindicated
* blood clots in the leg, or any condition in which compression of the thigh or transient ischemia is contraindicated (e.g. open wounds in the leg).
* history of hypertension
* history of heart failure
* Head injury within the previous 6 months
* Seizure disorder
* Adverse reaction to ultrasound gel
* History of thrombosis
* History of sickle cell trait

Primary outcomes:
measure: Change in quadriceps strength
timeFrame: through study completion, an average of 6 weeks
measure: Change in gait kinematics
timeFrame: through study completion, an average of 6 weeks
measure: Change in gait kinetics
timeFrame: through study completion, an average of 6 weeks
measure: Change in gait metabolics
timeFrame: through study completion, an average of 6 weeks
Secondary outcomes:
measure: Six-minute walk test
timeFrame: through study completion, an average of 6 weeks
Other outcomes:
Locations:
city: Chicago
country: United States
facility: UIC Physical Therapy Faculty Practice
state: Illinois
Study officials:
affiliation: University of Illinois at Chicago
name: Lindsay Slater, PhD
role: PRINCIPAL_INVESTIGATOR
References: